Biomarker Technologies Market: Proteomics, Mass Spectrometry, and Neurological Disease Biomarkers
Expanding clinical trial pipelines for Alzheimer and Parkinson diseases, breakthroughs in ultra-sensitive blood-based neurofilament testing, and high-throughput mass spectrometry platforms are driving rapid expansion in the proteomics and neurology segment of the Biomarker Technologies Market. Historically, diagnosing neurodegenerative pathology required expensive PET brain scans or invasive...
0 Comments 0 Shares 6 Views 0 Reviews